An update from Imac Holdings (BACK) is now available.
The Company has expanded its Board of Directors to five members, welcoming Dr. Peter Beitsch and Dr. Matthew Schwartz on June 26, 2024. Dr. Beitsch brings extensive experience in melanoma and breast cancer, with a distinguished history in surgical societies and research. Dr. Schwartz, a seasoned Radiation Oncologist, contributes a wealth of knowledge from his leadership roles in oncology centers and his involvement with advanced radiation treatment technologies. Both appointees are esteemed in their fields and hold no familial ties or disclosable financial interests with the Company’s current directors or officers.
Learn more about BACK stock on TipRanks’ Stock Analysis page.
